Skip to main content

Advertisement

Log in

In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy

  • IM - ORIGINAL
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

Abstract

The impact of chronic kidney disease (CKD) on the outcome of acute pulmonary embolism (PE) is uncertain. We aimed to evaluate the effect of renal dysfunction (defined by ICD-9-CM codification) on in-hospital mortality for PE. We considered all cases of PE (first event) recorded in the database of hospital admissions for the Emilia-Romagna region, Italy, from 1999 to 2009. The inclusion criterion was the presence, as a main discharge diagnosis, of acute PE codes according to ICD-9-CM. Diagnoses of immobilization, dementia, sepsis, skeletal fractures, hypertension, heart failure, myocardial infarction, diabetes mellitus, peripheral vascular disease, cerebrovascular disease, chronic pulmonary disease, pneumonia, malignancy, CKD and end-stage renal disease (ESRD) were also considered to evaluate comorbidity. The outcome was in-hospital mortality for PE, and multivariate logistic regression analyses was performed. We considered 24,690 cases of first episode of PE. In-hospital mortality for PE was not different in patients without renal dysfunction, with CKD, or ESRD (23.6 vs. 24 vs. 18 % p = ns). In-hospital mortality for PE was independently associated with age (OR 1.045, 95 % CI 1.042–1.048, p < 0.001), female sex (OR 1.322, 95 % CI 1.242–1.406, p < 0.001), hypertension (OR 1.096, 95 % CI 1.019–1.178, p = 0.013), diabetes mellitus (OR 1.120, 95 % CI 1.001–1.253, p = 0.049), dementia (OR 1.171, 95 % CI 1.020–1.346, p = 0.025), peripheral vascular disease (OR 1.349, 95 % CI 1.057–1.720, p = 0.016) and malignancy (OR 1.065, 95 % CI 1.016–1.116, p = 0.008). Age and comorbidity are associated with in-hospital mortality for PE, whereas CKD does not appear to be an independent predictor of adverse outcomes in patients hospitalized for PE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Foley RN, Collins AJ (2011) A novel model of cardiovascular risk based on kidney function. Am J Nephrol 34:505–511

    Article  PubMed  Google Scholar 

  2. Schena FP (2011) Management of patients with chronic kidney disease. Intern Emerg Med 6(suppl 1):S77–S83

    Article  Google Scholar 

  3. Manfredini R, Portaluppi F, Grandi E, Fersini C, Gallerani M (1996) Out-of-hospital sudden death referring to an emergency department. J ClinEpidemiol 49:865–868

    Article  CAS  Google Scholar 

  4. Squizzato A, Luciani D, Rubboli A et al (2012) Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. Intern Emerg Med. doi:10.1007/s11739-011-0725-1

    Google Scholar 

  5. Becattini C, Agnelli G (2007) Acute pulmonary embolism: risk stratification in the emergency department. Intern Emerg Med 2:119–129

    Article  PubMed  CAS  Google Scholar 

  6. Mossey RT, Kasabian AA, Wilkes BM, Mailloux LU, Susin M, Bluestone PA (1982) Pulmonary embolism low incidence in chronic renal failure. Arch Intern Med 142:1646–1648

    Article  PubMed  CAS  Google Scholar 

  7. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(Suppl. 1):S1–S266

    Google Scholar 

  8. de Jager DJ, Grootendorst DC, Jager KJ et al (2009) Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 302:1782–1789

    Article  PubMed  Google Scholar 

  9. Calderon K, Jhaveri KD, Mossey R (2010) Pulmonary embolism following thrombolysis of dialysis access: is anticoagulation relay necessary? Semin Dial 23:522–525

    Article  PubMed  Google Scholar 

  10. Finazzi G, Mingardi G (2009) Oral anticoagulant therapy in hemodialysis patients: do the benefits outweight the risks? Intern Emerg Med 4:375–380

    Article  PubMed  Google Scholar 

  11. Fabbian F, De Giorgi A, Pala M et al (2011) Low molecular weight heparins and glomerular filtration rate: a report to be considered. Curr Vasc Pharmacol 9:693–697

    Article  PubMed  CAS  Google Scholar 

  12. Lim W, Dentali F, Eikelboom JW, Crowther MA (2006) Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 144:673–684

    Article  PubMed  CAS  Google Scholar 

  13. Fairshter RD, Vaziri ND, Mirahmadi MK (1982) Lung pathology in chronic hemodialysis patients. Int J Artif Organs 5:97–100

    PubMed  CAS  Google Scholar 

  14. Wiesholzer M, Kitzwögerer M, Harm F et al (1999) Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin. Am J Kidney Dis 33:702–708

    Article  PubMed  CAS  Google Scholar 

  15. Tveit DP, Hypolite IO, Hshieh P et al (2002) Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis 39:1011–1017

    Article  PubMed  Google Scholar 

  16. Tveit DP, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC (2002) Risk factors for pulmonary embolism in chronic dialysis patients. J Nephrol 15:241–247

    PubMed  Google Scholar 

  17. Monreal M, Falgà C, Valle R et al (2006) Venous thromboembolism in patients with renal insufficiency: findings from the RIETE registry. Am J Med 119:1073–1079

    Article  PubMed  Google Scholar 

  18. Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR (2008) Chronic kidney disease increases risk for venous thromboembolism. J Am SocNephrol 19:135–140

    Google Scholar 

  19. Folsom AR, Lutsey PL, Wattanakit K, Heckbert SR, Cushman M (2010) Chronic kidney disease and venous thromboembolism: a prospective study. Nephrol Dial Transplant 25:3296–3301

    Article  PubMed  Google Scholar 

  20. Parikh AM, Spencer FA, Lessard D et al (2011) Venous thromboembolism in patients with reduced estimated GFR: a population based perspective. Am J Kidney Dis 58:746–755

    Article  PubMed  Google Scholar 

  21. Kumar G, Sakhuja A, Taneja A et al. (2012) Pulmonary embolism in patients with CKD and ESRD. Clin J Am Soc Nephrol (Jul 26 Epub ahead of print)

  22. Penaloza A, Roy PM, Kline J (2012) Risk stratification and treatment strategy of pulmonary embolism. Curr Opin Crit Care 18:318–325

    Article  PubMed  Google Scholar 

  23. Jiménez D, Aujesky D, Yusen RD (2010) Risk stratification of normotensive patients with acute symptomatic pulmonary embolism. Br J Haematol 151:415–424

    Article  PubMed  Google Scholar 

  24. Htike N, Superdock K, Thiruveedi S, Surkis W, Teehan G (2012) Evaluating proteinuria and nephrotic syndrome in patients with venous thromboembolism. Am J Med Sci 343:124–126

    Article  PubMed  Google Scholar 

  25. Mangione F, Dal Canton A (2011) Chronic kidney disease: myth and reality. Intern Emerg Med 6(suppl 1):S69–S76

    Article  Google Scholar 

  26. Di Minno MND, Tufano A, Ageno W, Prandoni P, Di Minno G (2012) Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. Intern Emerg Med 7:9–13

    Article  PubMed  Google Scholar 

  27. Fabbian F, Pala M, De Giorgi A et al (2012) In-hospital mortality in patients with renal dysfunction admitted for myocardial infarction: the Emilia-Romagna region of Italy database of hospital admissions. Int Urol Nephrol. doi:10.1007/s11255-012-0250-9

    PubMed  Google Scholar 

Download references

Acknowledgments

We deeply thank Dr. Franco Guerzoni and Dr. Nicola Napoli, Center for Health Statistics, AziendaOspedaliera-Universitaria, Ferrara, Italy, for precious and valuable collaboration. This paper is funded (in part) by a scientific institutional grant (FondoAteneoRicerca–FAR) by the University of Ferrara, Italy.

Conflict of interest

F. Fabbian, M. Gallerani, M. Pala, A. De Giorgi, R. Salmi, F. Manfredini, F. Portaluppi, F. Dentali, W. Ageno, and R. Manfredini have no conflict of interest; D.P. Mikhailidis has given talks, attended conferences and participated in advisory boards and trials sponsored by Merck, Sharp &Dohme and Genzyme. The authors are solely responsible for the design and conduct of this study, all study analyses, the drafting and editing of the paper, and its final contents.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fabio Fabbian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fabbian, F., Gallerani, M., Pala, M. et al. In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy. Intern Emerg Med 8, 735–740 (2013). https://doi.org/10.1007/s11739-012-0892-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-012-0892-8

Keywords

Navigation